A well-performing CMO network is critical for asset-light pharma companies as the ability to supply is often the main hindrance to growth. Root causes of issues include becoming locked in with underperforming CMOs, not finding and building up alternatives, or failing to run transfers efficiently. In this article, we present the A&M Sourcing Decision Framework and show how we have practically used it to help our clients become more agile and structured to reshape their CMO network and support future growth.
 

Download